Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neurovive Pharmaceutical AB Updates on Listing on NASDAQ OMX Stockholm


Wednesday, 10 Apr 2013 02:30am EDT 

Neurovive Pharmaceutical AB announced that its admission to NASDAQ OMX Stockholm will become effective and trading of the shares will start at 09.00 am (CET) April 10, 2013. The stock will be listed as a Small Cap company within the Healthcare sector and traded under the ticker symbol, NVP. No new shares have been issued in conjunction with the listing on NASDAQ OMX Stockholm. 

Company Quote

60.5
1.75 +2.98%
11 Jul 2014